TrialScientific reports2023

A multicenter, randomized, open-labelled, non-inferiority trial of sustained-release sarpogrelate versus clopidogrel after femoropopliteal artery intervention.

Ahram Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.